Europe’s damaging divisions over military aid to Ukraine - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
乌克兰战争

Europe’s damaging divisions over military aid to Ukraine

Nato allies need to do more to help Kyiv — by sending more weapons, not troops

Emmanuel Macron’s remark last week that sending western troops to Ukraine could not be ruled out was immediately slapped down by many European counterparts — notably German Chancellor Olaf Scholz. Russia’s Vladimir Putin still seized on the French president’s statement to make his most explicit threat yet of nuclear conflict. On Tuesday, Macron said he stood by his comment, urging European allies not to be “cowards” now that “war is back on our soil”.

The French president’s underlying message — that Nato members must be ready to do more to help Ukraine against resurgent Russian forces — is well founded. But this should be by sending more arms, not troops. His public talk of boots on the ground has wrongfooted allies and laid bare strategic divisions, particularly with Germany, over military assistance to Kyiv — just when a united front is needed.

French officials said Macron’s talk of troops was intended to introduce some ambiguity for Moscow over what Nato members might be ready to do, and he was referring to western forces carrying out non-combat functions behind the Ukrainian front lines. The French leader has a point that Ukraine’s allies have for too long allowed Putin a monopoly on threats of escalation.

The problem is that many counterparts have legitimate concerns that even limited troop deployments would put Nato on the path to direct confrontation with Moscow. Though they have stressed the need to aid Kyiv and asked voters to bear higher energy costs, many western leaders — not just Scholz — will fear that any talk of sending soldiers could turn sentiment against the war. It plays, too, into Moscow’s bogus narrative that this is a Nato-provoked conflict. It might also be misread by a conspiracy-minded Kremlin as evidence that western leaders are, indeed, plotting something broader.

With US arms deliveries held up by political blocks, and continuing shortfalls in European production, the priority must be to ensure Ukraine receives the weaponry it needs this year. This covers everything from scarce artillery shells to cruise missiles, fighters and air defence. Recent mutual accusations by France and Germany that the other is not doing enough have some substance, but are a fruitless distraction.

Over the past week Macron appears, rightly, to have dropped objections to using EU funds to buy weaponry for Ukraine outside the block. His previous insistence that European cash should go only towards rebooting Europe’s defence industry has been overtaken by Ukraine’s urgent need. On Tuesday, he pledged that France would contribute to a Czech plan to buy 800,000 shells on the world market — and would allow the European Peace Facility, a joint EU fund, to finance part of it.

Scholz, for his part, should lift his opposition to sending Taurus missiles, which have a longer range than cruise missiles supplied by France and the UK and which Ukraine is crying out for. His objection that German support staff would have to accompany them to Ukraine was contradicted by military officers in a conversation that was embarrassingly eavesdropped on by Moscow. And though the chancellor worries Kyiv might use them to hit targets inside Russia, Ukraine has respected limits imposed by Britain and France on how it can use their missiles.

Perhaps Macron’s most striking statement was that the “defeat” of Russia in Ukraine was now “indispensable to security and stability in Europe”. From a leader who called in 2022 for the west to avoid “humiliating” Moscow — and who has gone out of his way to understand and reason with Putin — this is a salutary message. Kyiv’s allies need a strategy to achieve this goal, without leading to escalation that spirals out of control.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

英国生物技术公司新药降低量身定制式癌症疗法副作用

Autolus用于治疗急性淋巴细胞白血病的新型Car-T细胞疗法在美国获批,该疗法与癌细胞结合所需时间更短,因此副作用更小。

前保守党财政大臣告诫工党现任勿看衰英国前景

杰里米•亨特表示,英国在关键增长领域表现强劲,应该停止贬低自己。

Lex专栏:游戏机制造商在低迷市场中表现强劲

虽然游戏机老化通常意味着游戏公司收入持续下降,但多年未推出新产品的索尼和任天堂等游戏公司仍表现强劲。

为年度展望报告辩护

巴克兰:定期回顾投资框架以及进行经济和市场展望是一项良好的做法。

企业长寿的奥秘为何对投资者很重要

长寿公司除了具有凝聚力、宽容度和财务保守等特征外,几乎没有什么共同点。
1天前

特朗普上台能否解决加拿大经济疲软问题?

经济学家表示,来自美国的冲击可能会使该国经济摆脱麻木状态。
设置字号×
最小
较小
默认
较大
最大
分享×